Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06382532

Diagnosis of Depressive Disorder Malinger Using the Niacin Skin Response Test (NSRT)

Biological Diagnostic Techniques for the Diagnosis of Depressive Disorders Malinger Based on the Niacin Skin Response Test (NSRT)

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
410 (estimated)
Sponsor
Air Force Military Medical University, China · Academic / Other
Sex
Male
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study will explore the specific response characteristics of the niacin skin response test in the population with depressive disorder malinger. The investigators expect that depressive disorder malinger can be discriminated by the niacin skin reaction test.

Detailed description

Depressive disorder malingers are prevalent, and it is difficult to recognize. As an objective and scientific endophenotype of depressive disorders, the blunted features in NSRT are determined by genetic factors and are not influenced by the mental state of individual subjects at a particular moment, which can provide a reliable retrospective biological index for the determination of mental and psychological state of depressive disorder malinger. This study will explore the specific response characteristics of the niacin skin response test in the population with depressive disorder malinger, explore the application prospects of this technology in the field of biological identification, and establish a high-specificity biological diagnostic model for depressive disorder malinger and validate and optimize it, so as to provide a biological basis for the accurate and efficient identification of depressive disorder malingers using objective indexes in the process of clinical practice.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNiacin skin reaction testNicotinic skin reaction, also known as nicotinic flush reaction, occurs when a solution of nicotinic acid methyl ester briefly contacts the skin. Following penetration through the skin barrier into the subcutaneous tissue, it generates nicotinic acid (vitamin B3). Under the action of phospholipase A2 (PLA2), cyclooxygenase (COX), and other enzymes, arachidonic acid (AA) on the cell membrane is cleaved to produce prostaglandins, leading to local vasodilation, increased blood perfusion, and the transient appearance of erythema on the skin.

Timeline

Start date
2024-05-01
Primary completion
2026-05-01
Completion
2026-05-01
First posted
2024-04-24
Last updated
2024-04-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06382532. Inclusion in this directory is not an endorsement.